<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    electroCore, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $426,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Francis R. Amato
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Bot Image, Inc.

    Bot Image, Inc.

    Bot Image has developed ProstatID, aiding in the early diagnosis of prostate cance...

    Bot Image has developed ProstatID, aiding in th...

    Amount Raised:    $61,598
    Fundraising Status:    EC
    Filing Type:    CF
    Fluidigm Corporation

    Fluidigm Corporation

    Fluidigm (NASDAQ:FLDM) is an industry-leading biotechnology tools provider with a ...

    Fluidigm (NASDAQ:FLDM) is an industry-leading b...

    Filing Type:    PU
    Medivie USA Inc

    Medivie USA Inc

    Medivie Therapeutic is an Israeli public company, which developed Laboraide – a ...

    Medivie Therapeutic is an Israeli public compan...

    Filing Type:    RA
    DarioHealth Corp.

    DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) co...

    DarioHealth Corp. (NASDAQ: DRIO) is a leading g...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...

    Filing Type:    PU
    Nektar Therapeutics

    Nektar Therapeutics

    Nektar Therapeutics is a research-based development stage biopharmaceutical compan...

    Nektar Therapeutics is a research-based develop...

    Filing Type:    PU
    AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the ...

    AcelRx Pharmaceuticals, Inc. is a specialty pha...

    Filing Type:    PU
    Phoenix PharmaLabs Inc

    Phoenix PharmaLabs Inc

    Phoenix PharmaLabs, Inc. (PPL) is a privately held, pre-clinical stage drug develo...

    Phoenix PharmaLabs, Inc. (PPL) is a privately h...

    Amount Raised:    $1,079,375.00
    Fundraising Status:    EC
    Filing Type:    CF
    Chiasma, Inc.

    Chiasma, Inc.

    Chiasma is focused on improving the lives of patients who face challenges associat...

    Chiasma is focused on improving the lives of pa...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.